EVENT WILL START IN
ABOUT PACTThe Patient Access Partnership is a patient-led multi-stakeholder network bringing together patients, the medical and public health community, industry and the European and member states policy makers and institutions, in order to develop and move forward on innovative solutions to reduce inequities in access to quality healthcare in the European Union.
- To facilitate the dialogue between European and national health stakeholders according to the mission
- To identify key hurdles in access to healthcare for patients in a holistic way
- To assess gaps in access to quality healthcare within EU member states
- To collaborate with relevant EU-led or national initiatives
- To develop innovative and sustainable solutions
THE “5As” OF ACCESSThe partners of PACT agreed on key principles supporting the notion of access: Availability, Adequacy, Accessibility, Affordability and Appropriateness, or in short – the “5As” principles.
The 5As principle stands for:
A system for financing health services so people do not suffer financial hardship when using them.
Services available must be relevant to the different parts of a population in terms of their health needs and material and cultural settings if the population is to ′gain access to satisfactory health outcomes′. In other words, available health care resources should meet the needs of different population groups.
MEP INTEREST GROUP ON ACCESSThe Members of the European Parliament (MEP) Interest Group on Patient Access to Healthcare is an informal group of MEPs committed to improve access to healthcare in Europe.
The supporting MEPs will advocate the model of partnership shared by the PACT and the IG, at Member States′ level
Amidst and in line with these developments, the Patient Access Partnership was formed - a patient-led multi-stakeholder network bringing together patients, the medical and public health community, industry and the EU and Member States policy-makers and institutions in order to develop and move forward on innovative solutions to reduce inequities in access to quality healthcare in the EU. In view of the significant challenges ahead, the Patient Access Partnership is determined to play a key role in contributing further to the efforts of improving access to healthcare.
The focus of the Conference will be provided by discussions on best practices and cooperation opportunities at regional and nation level, the implications and significance of the EU Semester, the opportunities that the EU structural funds provide as well as the added value and the practical implications of the UN Sustainable Development Goals.
- Discuss the barriers to ensuring equal access to quality healthcare in CEE countries;
- Encourage informative discussion on the existing sustainable mechanisms for improving healthcare systems, including actions in line with the recommendations set forward in the Sustainable Development Goals;
- Increase cooperation between policy-makers and stakeholders within and between the countries from the region;
- Raise awareness on the added value of existing best-practice examples of cooperation between stakeholders for improving access to healthcare and encouraging cooperation in neighbouring countries;
- Provide recommendations on follow-up actions to ensure better access to quality health services in the region
8:00 AM - 9:00 AM
9:00 AM - 10:30 AM
ROOM "Sofia Grand"
I. Setting the scene: health at the heart of sustainable development.
The session will delineate major public health challenges from a policy perspective that the EU faces in the last decade and efforts to address these issues.
Questions: What are the major public health challenges that the EU faces in the last decade? What are the key trends for improving health care management at the EU level? What are the opportunities for action in line with the recommendations of the Riga Roadmap?
- Dr. Petre Moskov, Minister of Health of the Republic of Bulgaria
- Mr. Stanimir Hasardzhiev, MD, Secretary-General, Patient Access Partnership
- Mr. Andrey Kovatchev MEP, Group of the European People's Party
- Mr. Šarūnas Narbutas, President of “Lithuanian Cancer Patient Coalition” (POLA) and Adviser to the President of the Republic of Lithuania
- Ms. Alyna C. Smith, Advocacy Officer – Health, Legal Strategies and Women, Platform for International Cooperation on Undocumented Migrants (PICUM)
10:30 AM - 11:30 AM
ROOM "Sofia Grand"
II. The state of play: measuring progress on EU actions to improve access.
The session will provide data on access to healthcare in the CEE countries.
Questions: What is the situation on the ground in the CEE countries? How far are we in terms of implementation of policies which aim to improve access? What are the key challenges in access that need to be addressed?
- Mr. Jan De Maeseneer M.D., PhD., (Hon) FRCGP, Vice-dean for strategic planning at the Faculty of Medicine and Health Sciences at Ghent University (Belgium) / Chairperson of the (former) Expert Panel on effective ways of investing in Health (EXPH)
- Mr. Yannis Natsis, Policy Coordinator Universal Access and Affordable Medicines, EPHA
11:30 AM - 12:00 AM
12:00 AM - 1:30 PM
ROOM "Sofia Grand"
III. How to improve access through cooperation? Best-practice examples.
The session will provide an opportunity for presentation of good and bad practice examples of cooperation from the region.
Questions: What examples of successful / unsuccessful models for cooperation exist? Can multi-stakeholder platforms help to improve health systems performance? What potential challenges may hinder these efforts? What was the critical success factor?
- “New voluntary collaborations on pharmaceutical policy: Belgium-Netherlands-Luxembourg-Austria take the initiative”, Marc Van de Casteele, MD PhD Coordinator of pharmaceutical assessment, Belgian Institute for Health Insurance and Invalidity
- Access to Essential Medicines for Greater Health Outcome”, Prof. Zoltán Kaló Professor of Health Economics, Eötvös Loránd University (ELTE) / Syreon Research Institute
- “How can Pragmatic Value Assessment (PrVA) benefit countries of the Central European region?”, Dr. Dávid Dankó, PhD, Managing Director, Ideas & Solutions
- “Improving access to health services for Roma and other vulnerable groups: the development of EU Roma Health Mediation Network”, Ms. Mariya Samuilova, Project officer, Migration Health Division, International Organization for Migration
- “Optimal treatment for all: European challenges and the way forward”, Mr. Denis Horgan, Executive Director, European Alliance for Personalised Medicine
- “Access to healthcare for migrants in the Czech Republic”, Ms. Elena Tulupova
- “Hindering Access to Treatment by Ill-devised cost-containment measures – Romanian experience”, Dr. Laurentiu Mihai
- “Health Inequalities in Europe”, Mr. Lucian-Andrei Despa
- “The relationship between occupational stress and the need for psychological primary help for medical personnel in Romania. Implications for the quality of life.”, Ms. Violeta Rotarescu
- “Supportive Counselling for the Cancer Patients and Kins at the Pharmacy”, Ms. Seda Kansu
1:30 PM - 2:30 PM
2:30 AM - 3:30 PM
ROOM "Sofia Grand"
IV. Improving access: existing and potential EU mechanisms
The session will provide information on the EU Semester, the EU Structural Funds and the Investment Plan for Europe as mechanisms to support national efforts to improve access.
Questions: What is the relevance, applicability and added value of the European Semester as an assessment mechanism for health systems performance? What funding opportunities do EU Structural and Investment Funds and the Investment Plan for Europe provide to improve health systems in the EU? What other possibilities exist?
- Mr. Artur Carvalho, European Commission, DG Health and Food Safety, Unit B1- Performance of national health systems
3:30 PM - 4:00 PM
4:00 PM - 5:30 PM
ROOM "Sofia Grand"
V. Improving access in practice.
Workshop: Roundtable discussions on possible actions to improve access through cooperation.
The representatives from each category gather by country (Bulgaria, Croatia, the Czech Republic, Hungary, Poland, Romania, Slovakia, Slovenia, Estonia, Latvia and Lithuania, including Greece, Macedonia, Serbia and Turkey).
Questions: What are the strengths and weaknesses of these tools? How applicable are they in your country? What are the major challenges and opportunities in using them?
Please identify 3 key recommendations on:
- ✔ Better use of the EU Semester as a mechanism to support health reforms at the national level
- ✔ Improving the implementation of EU Structural Funds to better meet the needs of the Member States
- ✔ Improving the cooperation between stakeholders at the national and international levels
5:30 PM - 6:00 PM
VI. Rapporteurs’ workshop
Moderator: Mr. Stanimir Hasardzhiev
9:00 AM - 10:30 AM
ROOM "Sofia Grand"
I. Improving access in practice.
Feedback on country roundtable discussions
10:30 AM - 10:45 AM
10:45 AM - 12:00 AM
ROOM "Sofia Grand"
II. The way forward: cooperation within the region: a way to improve access to quality healthcare CEE. Conclusions
- “European Pillar on Social Rights”, Mr. Artur Carvalho, European Commission, DG Health and Food Safety, Unit B1- Performance of national health systems
- Mr. Anders Olauson, Chairperson of PACT (moderator)
- Mr. Artur Carvalho, European Commission, DG Health and Food Safety (DG SANTE)
- Ms. Annabel Seebohm, LL.M, Secretary General, Standing Committee of European Doctors (CPME)
- Mr. Richard Bergstrӧm, Director General, European Federation of Pharmaceutical Industries and Associations (EFPIA)
- Mr. Adrian van den Hoven, Director General, Medicines for Europe (ME)
- Mr. Dominik Tomek, PharmD, MPH, PhD, Board of Directors (2014-2016), International Society for Pharmacoeconomics and Outcomes Research (ISPOR)
12:00 am - 12:15 am
Lunch / Departure
One of the main objectives of the PACT Regional Conference is to encourage informative discussion on the existing sustainable mechanisms for improving healthcare systems. For this reason, PACT announced an Open Call for Abstracts.
Abstracts submitted were relevant to the following topic: “How to improve access through cooperation? Best-practice examples.”
The selected abstracts were examples of successful national models for cooperation. More specifically, they address the following questions:
- Can multi-stakeholder platforms help to improve health systems performance?
- What potential challenges may hinder these efforts?
- What was the critical success factor?
The conference committee reviewed the submitted abstracts and selected abstracts within two categories: plenary presentations and posters.
Petre MoskovMinister of Health of Republic of Bulgaria
He graduated from Sofia Medical University with a specialty in Anesthesiology and Intensive Care. He has completed residency trainings in France, UK, Spain and USA.
Since 1994 he has been senior assistant at the Clinic for Anesthesiology and Intensive Care, St. Sofia University Multiprofile Hospital for Active Treatment, in Sofia.
In 2013 he was elected Deputy Chairman of Democrats for Strong Bulgaria political party.
He was elected Minister of Health of November 7, 2014 by the 43rd National Assembly.
Stanimir HasurdjievChairperson of the Bulgarian National Patients’ Organization (NPO)
Dr. Hasurdjiev has devoted himself to the work in the patients’ advocacy sector and in defense of patients’ rights. In 2011 and 2015, he represented the Bulgarian patients in the Supervisory Board of the National Health Insurance Fund.
As of May 2013, Dr. Hasurdjiev is a board member of the European Patients’ Forum as well as a member of several regional and international organizations and networks, e.g. World Hepatitis Alliance, European Community Advisory Board, International Capacity Building Alliance and others.
In addition, he is one of the initiators and founders of the joint initiative of the European Patients’ Forum and the Bulgarian National Patients’ Organization – the Patient Access Partnership (PACT) – a multi stakeholder platform for finding innovative solutions to reduce inequities in access to healthcare in Europe, where Stanimir takes the position of a Secretary-General.
Dr. Hasurdjiev serves as a Secretary of the initiative "Health Partnership" which was officially launched in March 2015 as a permanent consultative body to the Council of Ministers. The initiative is part of the "Objectives for Health 2020" paper by the Bulgarian Ministry of Health and follows the model of the European Patient Access Partnership platform, incorporating representatives of the patient organizations, governmental institutions, unions of medical practitioners, hospitals, industry and providers of health care services, appliances and facilities. The active Minister of Health in Bulgaria serves as the Chairperson of the new platform.
Stanimir Hasurdjiev has many Bulgarian and international awards, such as the Best Media Award for the World Hepatitis Day campaign in 2008 “Am I number 12”. In 2011 National Patients’ Organization was awarded a prize by Effie Worldwide Awards for its campaign “If the healthcare system doesn’t hear you”.
Dr. Andrey KovatchevMember of the Presidency of the European Parliament (Quaestor)
Šarūnas NarbutasAdviser to the President of the Republic of Lithuania
In the past 5 years, he has participated as a patient advocate speaker / moderator in over 50 high-level conferences throughout Europe and on an international scale and has led a debate on cancer-related issues at the national level and in front of European authorities. Since 2013 he is acting as a President of “Lithuanian Cancer Patient Coalition” (POLA).
Before joining the President’s team Šarūnas Narbutas has also served as a member of an advisory board to the Minister of Health of the Republic of Lithuania, as a member of a Lithuanian reimbursement committee and also as a deputy chair of the commission awarding damages to patients caused by a medical mal-practice, while also representing interest of cancer patients in dozens of governmental working groups. He is also a PhD candidate in Vilnius University Faculty of Law and reads lectures on Health Law, European Union Law and Public International Law.
Alyna C. SmithAdvocacy Officer, PICUM (Platform of International Cooperation on Undocumented Migrants)
Ms Smith is Advocacy Officer at PICUM, where she leads their work on access to health care and access to justice. Established in 2001, PICUM is a network of more than 150 organisations across 38 countries working to advance the rights of undocumented migrants. Before joining PICUM, Alyna was a litigation associate at a global law firm in New York where she developed an extensive pro bono practice in the areas of criminal justice, immigration law and human rights. Her prior work experience includes a clerkship with Canada’s Federal Court, and work on ethics, genetics and access to medicines for the World Health Organization. Alyna holds a bachelor’s degree in human biology and ethics, a master’s degree in philosophy, and a degree in law from the University of Toronto.
Prof. Jan De Maeseneer M.D., PhD., (Hon) FRCGP.Vice-dean for strategic planning at the Faculty of Medicine and Health Sciences
Academic career Jan De Maeseneer is involved in undergraduate and postgraduate teaching, training and research. He actually chairs the Educational Committee (since 1997) in charge of a fundamental reform of the undergraduate curriculum (from a discipline-based towards an integrated patient-based approach). This new curriculum has been evaluated very positively by an international Accreditation Board and has been awarded in 2005 a special quality award for its community orientation and social accountability. He is board member of the Interuniversity Flemish Consortium for vocational training of family medicine and he chairs the working party for family medicine of the Belgian High Council for medical specialists and family physicians (1998). In 2004 Prof. De Maeseneer received the "WONCA-award for excellence in health care: the Five-Star Doctor" at the 17th World Conference of Family Doctors in Orlando (USA). In 2008 he received a "Doctor Honoris Causa" degree at the Universidad Mayor de San Simon in Cochabamba (Bolivia). In 2010, he received the prize De Schaepdrijver-Caenepeel for developmental work from the Royal Flemish Academy of Medicine. In 2012 he was offered the title of Honorary Professor in the Centre for Primary Care and Public Health in Blizard Institute within Queen Mary, University of London. In 2014 he received the Special Award for Excellence in Health Professional Education at the Prince Mahidol Award Conference in Thailand.
Research The research activities are focused on: epidemiology of general practice, functioning of GPs, prescription behaviour, medical decision making, medical education, health systems research, equity in health care, telematics in health care, health outcome and health and poverty. He wrote articles in several journals on health education, epidemiology, medical decision making, medical education, quality of care, community oriented primary care, interdisciplinary team work, training in general practice, health and poverty, health in developing countries. Prof. De Maeseneer is the author of more than 150 scientific publications. More than 100 of them have been published in international journals with peer review-system. He also has given many lectures at international and national conferences. Since 1996 he is a member of the editorial board of the “European Journal of General Practice” and of the WICC (Wonca International Classification Committee). Prof. De Maeseneer is chairman of the European Forum for Primary Care since 2005 (www.euprimarycare.org). Since October 2010 he is Director of the International Centre for Primary Health Care and Family Medicine – Ghent University, that has been designated as a WHO Collaborating Centre on PHC. Since 2012 he is a member of the Global Forum on innovation of Health Professionals’education at the National Academies of Sciences, Engineering and Medicine (Washington).
Social accountability In 1990-1991, he has been advisor on primary health care of the federal Minister of Health. Since 2010, he is the Chairman of the Strategic Advisory Board of the Flemish Minister for Welfare, Health and Family. He has been member of the Advisory Committee on Medical Training of the EU and of the Scientific Advisory Board of the "Organisation for Accreditation and Quality Assurance" in Switzerland. From 2006 to 2008, Prof. J. De Maeseneer was a member of the Knowledge Network on "Health System" of the WHO Commission on Social Determinants of Health. He actually is a member of the Scientific Committee for the Renewal of Primary Health Care of WHO-Geneva. He has been the Chairman of the Expert Panel on Effective Ways of Investing in Health (EXPH), advising the European Commission from 2013 until 2016.
International cooperation Prof. De Maeseneer has been involved in the development of various programs of international cooperation and student exchange (University of Cochabamba in Bolivia, University of Cape Town in South Africa, University Yaounde I in Cameroon, University of Makerere in Kampala, University of Science and Technology in Mbarara – Uganda, University of Cuenca – Ecuador and Pontifica Universidad Catolica de Ecuador - Quito). He is promoter of the VLIR-Own Initiatives project on "Optimisation of family medicine training in Southern and Eastern Africa" that has an important impact on the development of primary health care. He is promotor of the Primafamed-network (www.primafamed.ugent.be). From 2007 - 2015, Jan De Maeseneer has been the Secretary General of the Network "Towards Unity for Health" (www.the-networktufh.org).
Languages: Dutch, English, French, German, Spanish.
Mr. Yannis NatsisPolicy Coordinator Universal Access and Affordable Medicines, EPHA
Dr Marc Van De Casteele, MD PhDCoordinator of pharmaceutical assessment Belgian Institute for Health Insurance and Invalidity
Zoltán KalóHead of the Institute of Economics at Eötvös Loránd University (ELTE) in Budapest
He received Bachelor of Economics degree from the Budapest University of Economics; Medical Doctor degree from the Semmelweis Medical University; MSc in Health Economics degree from the University of York; PhD in Pharmaceutical Sciences degree from the Semmelweis University; and DrHabil degree in Sociology from the ELTE University.
He has 20 years of international experience in academia and industry, specializing in health systems design, HTA implementation, health economics and outcomes research, economic modeling, patient access and pricing policies of healthcare technologies.
Dr. Kaló serves as a policy advisor to public decision-makers and global health care corporations. He was a Director of the International Society of Pharmacoeconomics and Outcomes Research (ISPOR) between 2012-2014, and the Chair of ISPOR Central and Eastern European Network Executive Committee between 2013-2015.
Selected list publications: http://www.ncbi.nlm.nih.gov/pubmed/?term=kalo+z
Dávid Dankó, PhDManaging director, Ideas & Solutions (I&S)
Dávid has 13 years of experience in health care management & the funding of pharmaceuticals and medical devices. Until 2010 he was member of the executive team for pharmaceutical reform in Hungary as deputy director of reimbursement at the national health insurance fund. He speaks regularly at conferences and workshops on pharmaceutical and medical device policies, gives payer communication and negotiation trainings to multinational companies and authorities and he has co-edited a university textbook titled ‘Pharmaceutical Reimbursement’.
- Pragmatic value assessment and HTA systems for middle-income markets
- Process and data transparency of pharmaceutical decision-making processes
- Linking managed entry agreements to value assessment of pharmaceuticals
- Negotiations and communication with payers and other governmental stakeholders
- Alternative funding strategies for middle and low-income countries
Dávid has lectured at the European Market Access University Diploma (EMAUD) programme, the Semmelweis University of Budapest, Debrecen University, Eötvös Loránd University and the former Vienna School of Clinical Research. He graduated in Economics from Corvinus University of Budapest and earned a PhD degree in 2012 with his thesis on resource management in pharmaceutical research & development.
Mariya SamuilovaProject officer, Migration Health Division, International Organization for Migration
Mr. Denis HorganExecutive Director of the European Alliance for Personalised Medicine (EAPM)
Artur CarvalhoEuropean Commission, DG Health and Food Safety, Unit B1- Performance of national health systems
Anders OlausonChairperson of the Patient Access Partnership (PACT) and an Honorary President of the European Patients’ Forum (EPF)
Anders is past member of the board of Eurordis, and was president from 1999 to 2001. He represented it as a member of the board of the European Patients’ Forum (EPF) until 2016. He has been president of EPF since June 2005 until 2016, when he was appointed Honorary President for EPF. Anders represents EPF in steering committees, which has been established by DG Sanco and DG Infso.
Between 2006 and 2012, Anders was a member of the advisory group for Health Research within DG Research. Since 2013/14, Anders is appointed member of the Horizon 2020 Advisory group for Societal Challenge - Configuration 'Health, demographic change and well-being’.
In 2005, Anders was accepted as a researcher within the PhD program at Gothenburg University. The Swedish Government appointed Anders to serve as a member of the Advisory Council at The National Board of Health and Welfare from 2008 - 2014.
Anders Olauson received HM The King of Sweden’s Medal for his valuable contributions in the field of disability. Anders was presented with the King’s medal 8th size, with the Seraphim Ribbon at the Royal Palace in Stockholm, the 28th of January 2010.
ANNABEL SEEBOHM LL.M.Secretary General of the Standing Committee of European Doctors (CPME)
Richard BergstrӧmDirector General, Director General, European Federation of Pharmaceutical Industries and Associations (EFPIA)
Adrian van den HovenDirector General, Medicines for Europe
Dr. Dominik Tomek, PharmD., PhD., MPHFounding member of the Slovak Society for Pharmacoeconomics, Slovak Agency for Health Technology Assessment and a founding member and the current president of ISPOR Chapter Slovakia
Dr. Tomek served for many years in the Drug Committee of State Institute for Drug Control, Pricing Committee of Ministry of Finance and Reimbursement Committee of Ministry of Health. He is teaching at the Faculty of Medicine, Slovak medical university, Bratislava, Slovakia. Dr. Tomek has a doctor degree in Clinical Pharmacy, a PhD. in the field of public health and degrees of postgraduate specializations in management of public pharmacy, preparation of radiopharmaceuticals, and revision pharmacy for health insurance, pharmacoeconomics, in management of public health and in market access. He studied Market Access at the University of Lyon with Prof. Mondher Toumi in EMAUD class.
He pioneered Patient Empowerment and patient education in Slovakia. Since 2010 he is teaching, training and lecturing patients in the field of treatment adherence, prevention, communication, health economy and other drug policy and health policy issues. He initiated patient education on the Faculty of Medicine, where he is supervising this education. As a patient himself, a patient relative and a long time health care provider, is he a dedicated patient advocate. He is vice president and scientific advisor to the Association for the Protection of Patient Rights in Slovak republic and Board Member of the European Patients Forum in Brussels.
James Bourchier Boulevard 100
TRANSPORTATION AND DIRECTIONS
The hotel is located in the green area of Sofia, close to the city center. Hotel Marinela is one of the landmarks of the city.
PACT will be providing transfers from and to the airport (upon prior notification by the organisers). Alternatively, you can arrive by using one of the following options:
By metro (Terminal 2 - Hotel Marinela):
Take M1 from “Sofia Airport” station to “Serdika” station. Change to M2 (direction “Vitosha” station) to “James Bourchier” station. Exit towards “Zlaten rog” Street. Take the right through the park until you reach Hotel Marinela (about 200 m.).
GPS coordinates (Latitude: N 42.6978 / 42°42'52; Longitude: E 23.3217 / 23°20'18)
For your comfort and safety, we recommend the services of the taxi operator OK Supertrans AD as contractual partner of Sofia Airport.
You can request the service at the offices of OK Supertrans in the Arrivals of Terminal 1 and Terminal 2 (+359 2 973 2121; www.oktaxi.net). The floor markings in yellow will lead you to the taxi stand area.
We recommend that you do not use taxi services offered outside the office of the taxi operator or in front of the terminal to avoid the risk of abuse.